U.S. flag

An official website of the Department of Health & Human Services

AHRQ: Agency for Healthcare Research and Quality

Substance Use Tools & Resources   

Read the Guide

This collection of tools and resources is for providers, staff, and patients who offer or use services to address substance use, and other interested stakeholders. This collection was originally established following an environmental scan on implementing medication-assisted treatment (MAT) for opioid use disorder (OUD) in rural primary care. (See PDFs of Volume 1 (PDF - 609 KB) and Volume 2 (PDF - 1.3 MB) of that scan). Items have been continuously added to this collection since then, and the collection has expanded to cover substance use more broadly, rather than just MAT for OUD.

Displaying 481 - 490 of 1023

Practice Guidelines for the Administration of Buprenorphine for Treating Opioid Use Disorder

These guidelines provide eligible clinicians who are state licensed and registered by the DEA to prescribe controlled substances, an exemption from certain statutory certification requirements related to training, counseling and other ancillary services.
Format
Other
Audience
Medical Providers
Behavioral Health Providers
Other Team Members
Source
Department of Health and Human Services (HHS)
Year
Resource Type
PDF

Prescription Opioids DrugFacts

This NIDA web page includes facts and figures on prescription opioids.
Format
Web Page
Audience
Medical Providers
Behavioral Health Providers
Other Team Members
Patients
Source
National Institute on Drug Abuse (NIDA)
Year
Resource Type
Web Page

Progress Note Example (PDF - .11 MB)

Provides an example of a progress note for buprenorphine/naloxone maintenance treatment.

Format
Instrument/Protocol
Audience
Medical Providers
Other Team Members
Source
Providers Clinical Support System
Year

Proposed Guidance for Toxicology Testing of Pregnant Patients (PDF - 88.1 KB)

This guidance provides recommendations for screening pregnant patients for substance use disorder (SUD) to enhance the well-being of the maternalfetal dyad.

Format
Instrument/Protocol
Audience
Behavioral Health Providers
Medical Providers
Source
State of Maine Department of Health and Human Services
Year
Resource Type
PDF

Protocol for Follow-up Appointments (PDF - .06 MB)

Lists activities that should be performed during followup appointments and behaviors that should be addressed with the patient.

Format
Instrument/Protocol
Audience
Medical Providers
Source
Providers Clinical Support System
Year

Rapid Opioid Dependence Screen (RODS) (PDF - 273 KB)

The RODS is an 8-item screening tool to assess opioid depdence and the need for services for opioid use or withdrawal that require medical attention.
Format
Instrument/Protocol
Audience
Medical Providers
Behavioral Health Providers
Other Team Members
Source
Wickersham, JA; et al.
Year
Resource Type
PDF

Reducing Stigma Toward Families Impacted by Opioid Use Disorder (PDF - 1.18 MB)

The purpose of this resource guide is to share practical strategies and resources implemented by the Neonatal Abstinence Syndrome (NAS) Investment Program awardees for addressing opioid use disorder (OUD) stigma in hospitals treating pregnant and parenting women with OUD.
Format
Guide
Audience
Medical Providers
Behavioral Health Providers
Other Team Members
Source
Massachusetts Health Policy Commission
Year
Resource Type
PDF

Reimbursement for Medications for Addiction Treatment Toolkit (PDF - 2.8 MB)

This guide provides considerations and strategies for clinicians and organizations implementing evidence-based practices. Approaches presented will assist clinicians, behavioral health organizations, primary care providers, insurers, and policy makers in understanding, selecting, and implementing evidence-based interventions that support adults with concurrent substance use and/or concurrent substance use disorders, including alcohol.

Format
Toolkit
Audience
Behavioral Health Providers
Medical Providers
Other Team Members
Policymakers and Payers
States
Source
American Society of Addiction Medicine (ASAM)
Year
Resource Type
PDF

Safe Use of Benzodiazepines: Clinical, Regulatory, and Public Health Perspectives

This two-day public workshop convened regulators, academic researchers, clinicians, patient advocates, and other stakeholders to share information underlying this action and gather input related to the safe use of benzodiazepines.
Format
Webinar/Video
Audience
Medical Providers
Behavioral Health Providers
Other Team Members
Communities
Policymakers and Payers
Source
Duke-Margolis Center for Health Policy / Food and Drug Administration (FDA)
Year
Resource Type
Video